|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
RGEN | Cox John | Director | Mar 24 | Sale | 96.72 | 1,858 | 179,706 | 923 | Mar 26 07:31 PM |
RGEN | Cox John | Director | Mar 18 | Sale | 95.27 | 26,736 | 2,547,035 | 2,781 | Mar 20 04:25 PM |
RGEN | Cox John | Director | Mar 04 | Sale | 93.39 | 10,000 | 933,900 | 2,781 | Mar 05 05:52 PM |
RGEN | Cox John | Director | Feb 24 | Sale | 92.81 | 4,455 | 413,455 | 2,781 | Feb 26 04:27 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 25 | Sale | 449.06 | 12,010 | 5,393,211 | 25,567 | Mar 26 04:31 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 01 | Sale | 114.37 | 2,175 | 248,755 | 9,588 | Nov 03 10:52 AM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 21 | Sale | 100.00 | 4,350 | 435,000 | 10,353 | Apr 25 02:02 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 13 | Sale | 80.00 | 36,234 | 2,898,720 | 10,353 | Apr 15 11:50 AM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Apr 11 | Sale | 78.00 | 6,900 | 538,200 | 10,353 | Apr 13 10:14 AM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 31 | Sale | 73.00 | 2,840 | 207,320 | 9,818 | Apr 01 03:20 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Mar 02 | Sale | 70.10 | 4,041 | 283,259 | 9,818 | Mar 03 03:10 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Feb 17 | Sale | 67.08 | 1,843 | 123,620 | 13,603 | Feb 18 03:06 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 09 | Sale | 62.87 | 773 | 48,597 | 16,356 | Nov 10 02:21 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Nov 02 | Sale | 63.04 | 765 | 48,228 | 17,129 | Nov 03 01:50 PM |
BIIB | Cox John | EVP Pharmaceutical Oper & Tech | Oct 28 | Sale | 63.00 | 6,900 | 434,700 | 18,254 | Oct 29 02:25 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite